Lumigan is Brimatoprost 0.03% which is prescribed for Glaucoma. Latisse which was discovered as an accidental side effect of Lumigan, was repackaged with applicators and remarketed as Latisse once it was FDA approved for this indication. My understanding is that they are both exactly the same down to the bottle and the dropper because if there were any changes then Allergan would have had to do more extensive studies. That being said, it is still a good idea to get Latisse for promoting eyelash growth and not Lumigan. There is the need for the applicators which have been specially designed for the usage, and it is being prescribed for that product which provides a safety net for the consumer/patient. Also, I do not believe that there is a significant pricing difference between Lumigan and Latisse, and it would be unethical to prescribe Lumigan stating that it was for glaucoma when in fact it was not. Therefore the short answer is yes they are the same medication but if you want Latisse then get Latisse.